Global pharmaceutical giant Pfizer is entwined in a legal battle with Australian competition regulators, reports say, regarding a dispute over the sale of the generic form of Lipitor.
Reports say the Australian Competition and Consumer Commission filed a law suit against Pfizer on Thursday regarding its contracts with pharmacies made in 2012. The ACCC says the agreements required pharmacies to purchase a 12-month supply of the generic in order to receive discounts; the agreements were struck just before the Lipitor patent expired in May, 2012.
ACCC head Rod Sims offered a statement, claiming Pfizer made the agreements “for the purpose of deterring or preventing competitors in the market for [the Lipitor generic] from engaging in competitive conduct.”
Pfizer similarly offered a statement to defend itself, saying it believes the contracts it struck with pharmacies were competitive.
Reports say the ACCC’s case against the pharmaceutical company simultaneously raises public awareness of patent issues; Sims told reporters that this is “an important public interest issue regarding the conduct of a patent holder nearing the expiry of that patent.”
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Spain’s Antitrust Watchdog Clears BBVA’s Sabadell Bid With Conditions
Apr 30, 2025 by
CPI
JetBlue and United Airlines Explore Strategic Partnership Following Collapse of NEA
Apr 30, 2025 by
CPI
House Passes ‘Take It Down Act,’ the First Major AI-Related Federal Regulation
Apr 29, 2025 by
CPI
Michigan Sues Express Scripts, Prime Therapeutics for Alleged Price-Fixing Scheme
Apr 29, 2025 by
CPI
Tech Rivals Testify as FTC Antitrust Trial Against Meta Enters Defining Phase
Apr 29, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece